Asma al-Assad, wife of ousted Syrian president, said to have ’50/50′ chance of survival as leukemia returns

This handout picture released by the Syrian Presidency Facebook page on August 8, 2018, shows the Syrian First Lady Asma al-Assad carrying papers as she begins treatment for early-stage breast cancer at a hospital in the capital Damascus. (AFP Photo/Syrian Presidency Facebook Page)
This handout picture released by the Syrian Presidency Facebook page on August 8, 2018, shows the Syrian First Lady Asma al-Assad carrying papers as she begins treatment for early-stage breast cancer at a hospital in the capital Damascus. (AFP Photo/Syrian Presidency Facebook Page)

Asma al-Assad, the wife of ousted Syrian president Bashar al-Assad, is said to have a 50% chance of survival after an aggressive form of blood cancer is believed to have returned following treatment for the disease earlier this year, the UK’s Telegraph newspaper reports.

According to the report, the exiled former first lady, who was diagnosed with acute myeloid leukemia in May of this year, is completely isolated in Moscow as she undergoes treatment for the aggressive cancer.

An unnamed source tells the Telegraph that she is “dying,” although another source says that “she has been 50/50 in the last few weeks.”

While her husband fled to Moscow after his brutal regime was toppled in a lightning rebel offensive earlier this month, Asma is said to have already been in Russia for some time before that as she was seeking treatment there.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.